BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21085073)

  • 1. Naltrexone in the treatment of opioid dependence.
    George S; Ekhtiari H
    Br J Hosp Med (Lond); 2010 Oct; 71(10):568-70. PubMed ID: 21085073
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Degenhardt et al.: 'depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy'.
    Brewer C
    Drug Alcohol Rev; 2008 Jul; 27(4):447-8; author reply 448-9. PubMed ID: 18584398
    [No Abstract]   [Full Text] [Related]  

  • 3. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
    Poser W; Ehrenreich H
    Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453
    [No Abstract]   [Full Text] [Related]  

  • 4. Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy.
    Degenhardt L; Gibson A; Mattick RP; Hall W
    Drug Alcohol Rev; 2008 Jan; 27(1):1-3. PubMed ID: 18034375
    [No Abstract]   [Full Text] [Related]  

  • 5. Risks associated with the inappropriate use of naltrexone in the treatment of opioid dependence.
    Latt NC
    Med J Aust; 1999 Nov; 171(9):500-1. PubMed ID: 10615348
    [No Abstract]   [Full Text] [Related]  

  • 6. What you need to know: addiction--prescribing naltrexone.
    Yeo BK
    Singapore Med J; 1997 Feb; 38(2):92-3. PubMed ID: 9269372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Limited role of naltrexone in the treatment of opiate addiction].
    van Brussel GH
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone: Not Just for Opioids Anymore.
    Sudakin D
    J Med Toxicol; 2016 Mar; 12(1):71-5. PubMed ID: 26546222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in opioid antagonist treatment for opioid addiction.
    Ling W; Mooney L; Wu LT
    Psychiatr Clin North Am; 2012 Jun; 35(2):297-308. PubMed ID: 22640757
    [No Abstract]   [Full Text] [Related]  

  • 10. Active surveillance of adverse events associated with naltrexone in New South Wales.
    Thackway SV; Ward PL; Taylor LK
    Med J Aust; 1999 Nov; 171(9):499-500. PubMed ID: 10615347
    [No Abstract]   [Full Text] [Related]  

  • 11. Vivitrex (Alkermes/Cephalon).
    Heading CE
    Curr Opin Investig Drugs; 2006 Jan; 7(1):81-8. PubMed ID: 16425675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP;
    Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts.
    Miotto K; McCann MJ; Rawson RA; Frosch D; Ling W
    Drug Alcohol Depend; 1997 Apr; 45(1-2):131-4. PubMed ID: 9179515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid antagonists: do they have a role in treatment programs?
    O'Brien CP; Greenstein RA; Evans B; Woody GE; Arndt R
    NIDA Res Monogr; 1983 Apr; 43():71-8. PubMed ID: 6410281
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid-dependent error processing.
    Fellows-Smith J
    J Opioid Manag; 2011; 7(6):443-9. PubMed ID: 22320026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unintentional rapid opioid detoxification: case report.
    Singh SM; Sharma B
    Psychiatr Danub; 2009 Mar; 21(1):65-7. PubMed ID: 19270623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alcohol consumption in opioid-dependence patients in treatment with naltrexone].
    Ochoa Mangado E; Arias Horcajadas F
    Actas Esp Psiquiatr; 2000; 28(4):239-49. PubMed ID: 11116795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do antagonists have a role in the treatment of opioid dependence?
    Jaffe JH
    Addiction; 2006 Apr; 101(4):468-9. PubMed ID: 16548923
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategies to maximize the efficacy of naltrexone for alcohol dependence.
    O'Malley SS
    NIDA Res Monogr; 1995; 150():53-64. PubMed ID: 8742772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.